
WELCOME TO THE WiNTER LAB
The Winston Neuroimaging and Translational Epilepsy Research Laboratory
![]() | ![]() | ![]() | ![]() | ![]() |
---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() |
![]() |

About the Lab
The Winston Neuroimaging and Translational Epilepsy Research Laboratory (WiNTER Lab) was founded to improve the understanding of the comorbidities of epilepsy and the diagnosis and surgical treatment of people with epilepsy primarily through neuroimaging techniques and translation into clinical practice. This has developed into employing more multimodal approaches, including robotic technology, neuropsychology, EEG and machine learning.
The lab moved to the Centre for Neuroscience Studies at Queen’s University in 2019 having previously been at the UCL Queen Square Institute of Neurology in London, UK. We work closely with Kingston Health Sciences Centre District Epilepsy Centre and have active collaborations with the School of Computing at Queen’s University, as well as within and outside Canada.
LAB NEWS
Our Recent Highlights
WiNTER LAB STUDENTS PRESENT THEIR RESEARCH
CONGRATULATIONS!
The WiNTER lab congratulates our former 4th year undergraduate research project students! Danielle Joyce won the Research Poster Day Award for her project on Epilepsy and APOE4, while Kristen Kyone recently accepted an offer for University of Toronto Medical School! Best wishes to them both!!
RECENT PUBLICATIONS
Congratulations to Theo Aliyianis on publishing the review he wrote during his MSc
on the effect of cognitive impairment on quality-of-life in people with epilepsy
WELCOME NEW LAB MEMBERS!
The WiNTER lab welcomes two new members staring in May, 2025. Dr. Amin Jalali joins as a postdoctoral researcher with expertise in AI and deep learning methods for neuroimaging.
PhD. candidate Amr Mustafa has studied EEG and completed a MSc in AI and data science and will be joining the First Seizure study.